- Investing Ideas
- /
- Banks Healthcare Sector
Banks Healthcare Sector
Results
2308
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,308 companies
Ardelyx
Market Cap: US$928.3m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$4.06
7D
15.0%
1Y
-48.8%
Spyre Therapeutics
Market Cap: US$916.2m
A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).
SYRE
US$14.88
7D
-0.3%
1Y
-59.6%
Arcus Biosciences
Market Cap: US$906.4m
A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.
RCUS
US$8.71
7D
-1.0%
1Y
-48.1%
Pharvaris
Market Cap: US$902.4m
A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.
PHVS
US$16.69
7D
-0.7%
1Y
-19.2%
Extendicare
Market Cap: CA$1.2b
Through its subsidiaries, provides care and services for seniors in Canada.
EXE
CA$14.73
7D
2.9%
1Y
88.1%
Intellia Therapeutics
Market Cap: US$880.5m
A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.
NTLA
US$8.50
7D
-0.6%
1Y
-67.2%
Avadel Pharmaceuticals
Market Cap: US$871.6m
Operates as a biopharmaceutical company in the United States.
AVDL
US$9.01
7D
-6.0%
1Y
-42.6%
HealthStream
Market Cap: US$869.7m
Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.
HSTM
US$29.13
7D
6.1%
1Y
5.9%
AMN Healthcare Services
Market Cap: US$868.7m
Provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.
AMN
US$22.42
7D
-0.9%
1Y
-62.4%
Niagen Bioscience
Market Cap: US$864.4m
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$10.93
7D
16.4%
1Y
245.9%
SI-BONE
Market Cap: US$843.3m
A medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.
SIBN
US$19.45
7D
3.6%
1Y
35.1%
CureVac
Market Cap: US$837.6m
A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
CVAC
US$3.72
7D
2.8%
1Y
9.4%
CorMedix
Market Cap: US$832.9m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$12.75
7D
7.5%
1Y
152.5%
Enliven Therapeutics
Market Cap: US$827.3m
A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.
ELVN
US$16.85
7D
-11.4%
1Y
-29.8%
Cronos Group
Market Cap: CA$1.1b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$2.98
7D
4.2%
1Y
-25.3%
Zymeworks
Market Cap: US$816.0m
A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).
ZYME
US$11.82
7D
-1.7%
1Y
31.6%
Geron
Market Cap: US$808.9m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.39
7D
8.6%
1Y
-62.7%
Bicara Therapeutics
Market Cap: US$789.1m
A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.
BCAX
US$15.21
7D
7.2%
1Y
n/a
Xeris Biopharma Holdings
Market Cap: US$781.6m
A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.
XERS
US$4.87
7D
-1.6%
1Y
137.6%
Syndax Pharmaceuticals
Market Cap: US$778.7m
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$9.30
7D
-15.4%
1Y
-54.1%
Nuvation Bio
Market Cap: US$769.0m
A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.
NUVB
US$2.30
7D
7.0%
1Y
-33.9%
WELL Health Technologies
Market Cap: CA$1.1b
Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.
WELL
CA$4.19
7D
2.9%
1Y
10.0%
LENZ Therapeutics
Market Cap: US$754.6m
Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
LENZ
US$28.45
7D
-3.1%
1Y
53.0%
Praxis Precision Medicines
Market Cap: US$754.1m
A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.
PRAX
US$37.35
7D
-2.8%
1Y
-17.0%
uniQure
Market Cap: US$750.1m
Develops treatments for patients suffering from rare and other devastating diseases in the United States.
QURE
US$14.68
7D
11.6%
1Y
202.7%
Nurix Therapeutics
Market Cap: US$728.8m
A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.
NRIX
US$9.51
7D
-6.6%
1Y
-41.3%
Veradigm
Market Cap: US$713.3m
A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.
MDRX
US$4.40
7D
4.8%
1Y
-43.2%
Anavex Life Sciences
Market Cap: US$710.3m
A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.
AVXL
US$8.44
7D
-1.3%
1Y
90.5%
Embecta
Market Cap: US$702.5m
A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.
EMBC
US$11.62
7D
-6.4%
1Y
-16.6%
Immunome
Market Cap: US$701.3m
A clinical-stage biotechnology company, develops targeted cancer therapies.
IMNM
US$8.01
7D
0.9%
1Y
-42.0%
Rocket Pharmaceuticals
Market Cap: US$700.3m
Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.
RCKT
US$6.45
7D
-7.9%
1Y
-71.7%
Akebia Therapeutics
Market Cap: US$685.5m
A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.
AKBA
US$2.80
7D
15.2%
1Y
143.5%
IRADIMED
Market Cap: US$685.5m
Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally.
IRMD
US$53.91
7D
2.5%
1Y
23.1%
GH Research
Market Cap: US$681.1m
Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.
GHRS
US$10.98
7D
8.1%
1Y
-17.3%
Nika Pharmaceuticals
Market Cap: US$672.8m
A pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases.
NIKA
US$0.66
7D
n/a
1Y
-6.1%
Mesa Laboratories
Market Cap: US$665.2m
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
MLAB
US$118.55
7D
-7.4%
1Y
-2.5%